CERA

Festive season appeal 2020

Help us put hope in sight

This festive season, we need your support to make more sight-saving discoveries possible, bringing hope to people affected by vision loss and blindness.

Our world-class research is devoted to discovering better ways to treat eye conditions that lead to vision loss and blindness. Achieving earlier diagnosis gives us the best chance of saving sight.

At CERA, our researchers are making advances with unique imaging technologies that allow us to see the structure of the eye like never before.

Combined with artificial intelligence, these methods have remarkable potential for improving early detection of conditions such as glaucoma, diabetic retinopathy and age-related macular degeneration.

The earlier these conditions are detected, the better chance we have of helping patients keep their sight.

Your donation this festive season will help us develop new technologies, advancing eye research with real-life impact.
   

From space technology to the eye clinic

“This festive season, we are excited to share with you our advances in unique imaging technologies and deep learning methods that are transforming the way we diagnose ageing eye diseases,” says Associate Professor Peter van Wijngaarden, Deputy Director at CERA.

CERA researchers have used a revolutionary type of imaging – similar to technology used by NASA satellites – to detect the early signs of Alzheimer’s disease through changes in the retina (the back of the eye).

Now, we are investigating ways to use this new technology to detect early signs of ageing eye diseases that lead to vision loss and blindness.

There is an urgent need to advance these technologies for use in eye clinics. Our vision is for this technology to become the new standard of eye care in Australia and around the world.

Finding earlier signs of glaucoma damage

Glaucoma is a neurodegenerative disease and a leading cause of vision loss and blindness in older people.

Treatments to delay the progression of the disease are usually effective when started early in the disease course. Unfortunately, about half of all glaucoma is undiagnosed, meaning that the opportunity to treat the disease at its early stages is lost for many people.

Our ground-breaking retinal imaging method seeks to detect signs of injury in glaucoma before irreversible damage is done, paving the way to more effective treatments.

Detecting diabetic retinopathy

Diabetic retinopathy is another leading cause of avoidable vision loss and blindness. It is estimated that 70,000 Australians have vision-threatening diabetic retinopathy and the number is expected to double by 2030.

Current eye screening examinations for diabetic retinopathy save sight, but tools to better identify those people at the highest risk of vision loss from the disease could have an enormous impact. People at high risk could be monitored more closely and undergo sight-saving treatments at the right time.

Our new imaging method has shown promise in detecting new markers of disease risk in people with diabetes and we are keen to proceed with further research to bring these advances to the clinic.

Thank you for your support this festive season

From everyone at CERA, we are sincerely grateful for your support of our ground-breaking research.

Every donation ­– no matter the size ­– brings our researchers one step closer to finding and advancing new technologies that will help save sight.

Thank you for helping us bring hope to people affected by vision loss and blindness.